A Prospective Multicenter Cohort Study of Late Physical Psychological and Social Effects in Patients Treated With Ipilimumab for Advanced Melanoma
Phase of Trial: Phase IV
Latest Information Update: 18 Jul 2018
At a glance
- Drugs Ipilimumab (Primary)
- Indications Malignant melanoma
- Focus Therapeutic Use
- Sponsors Bristol-Myers Squibb
- 10 Jul 2018 Planned End Date changed from 7 May 2018 to 30 Oct 2020.
- 10 Jul 2018 Planned primary completion date changed from 7 May 2018 to 29 May 2020.
- 17 Oct 2017 New trial record